5-Hydroxytryptamine2A receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats

Neuroscience

Volumn 117, Issue 4, 2003, Pages 939-948

  Blessing, W W ^a   Seaman, B ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

Body temperature; Hallucinogens; Hyperthermia; MDMA; Serotonin; Skin blood flow

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; AC 90179; KETANSERIN; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BODY TEMPERATURE; CONSCIOUSNESS; CONTROLLED STUDY; DOPPLER FLOWMETRY; DOSE RESPONSE; DRUG EFFECT; EXTERNAL EAR; HEART RATE; HYPERTHERMIA; MESENTERY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RABBIT; RAT; REGULATORY MECHANISM; SKIN BLOOD FLOW; SYMPATHETIC NERVE; SYMPATHETIC TRUNK; TAIL; VASOCONSTRICTION;

EID: 0037430746     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00810-2     Document Type: Article

References (59)

1. Ackner B., Pampiglione G. Some relationships between peripheral vasomotor and EEG changes. J Neurol Neurosurg Psychiatry. 20:1957;58-64.
2. Aghajanian G.K., Marek G.J. Serotonin and hallucinogens. Neuropsychopharmacology. 21:1999;16S-23S.
3. Aghajanian G.K., Marek G.J. Serotonin model of schizophrenia emerging role of glutamate mechanisms. Brain Res Rev. 31:2000;302-312.
4. Alper R.H. Hemodynamic and renin responses to (±)-DOI, a selective 5-HT2 receptor agonist, in conscious rats. Eur J Pharmacol. 175:1990;323-332.
5. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 38:1999;1083-1152.
6. Black J.L., French R.J., Mylecharane E.J. Receptor mechanisms for 5-hydroxytryptamine in rabbit arteries. Br J Pharmacol. 74:1981;619-626.
7. Blatteis C.M., Hales J.R., Fawcett A.A., Mashburn T.A. Jr. Fever and regional blood flows in wethers and parturient ewes. J Appl Physiol. 65:1988;165-172.
8. Blessing W.W., Nalivaiko E. Raphe magnus/pallidus neurons regulate tail but not mesenteric arterial blood flow in rats. Neuroscience. 105:2001;923-929.
9. Bolt G.R., Saxena P.R. Cardiovascular profile and hypotensive mechanism of ketanserin in the rabbit. Hypertension. 7:1985;499-506.
10. Callaway C.W., Clark R.F. Hyperthermia in psychostimulant overdose. Ann Emerg Med. 24:1994;68-76.
11. Clark W.G. Changes in body temperature after administration of antipyretics, LSD, delta 9-THC and related agents. Neurosci Behav Rev. 11:1987;35-96.
12. Cornea-Hebert V., Riad M., Wu C., Singh S.K., Descarries L. Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol. 409:1999;187-209.
13. Dabiré H., Chaouche-Teyara K., Cherqui C., Fournier B., Laubie M., Schmitt H. Characterization of DOI, a putative 5-HT2 receptor agonist in the rat. Eur J Pharmacol. 168:1989;369-374.
14. Dedeoglu A., Fisher L.A. Central and peripheral injections of the 5-HT2 agonist, 1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms. J Pharmacol Exp Ther. 259:1991;1027-1134.
15. Ferrer G.R., Goldner R.D. Experimental physiological studies with lysergic acid diethylamide (LSD-25). Arch Neurol Psychiatry. 65:1951;581-588.
16. Fiorella D., Helsley S., Lorrain D.S., Rabin R.A., Winter J.C. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. III The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion. Psychopharmacology (Berl). 121:1995;364-372.
17. Garcia J.N., Pedersen N.P., Nalivaiko E., Blessing W.W. Tail artery blood flow measured by chronically implanted Doppler ultrasonic probes in unrestrained conscious rats. J Neurosci Methods. 104:2001;209-213.
18. Glennon R.A. Do classical hallucinogens act as 5-HT2 agonists or antagonists? Neuropsychopharmacology. 3:1990;509-517.
19. Glennon R.A., McKenney J.D., Lyon R.A., Titeler M. 5-HT1 and 5-HT2 binding characteristics of 1-(2, 5-dimethoxy-4-bromophenyl)-2-aminopropane analogues. J Med Chem. 29:1986;194-199.
20. Grant R.T. Further observations on the vessels and nerves of the rabbit's ear, with special reference to the effects of denervation. Clin Sci. 2:1935;1-33.
21. Grant R.T., Bland E.F., Camp P.D. Observations on the vessels and nerves of the rabbit's ear with special reference to the reaction to cold. Heart. 16:1932;69-101.
22. Gudelsky G.A., Koenig J.I., Meltzer H.Y. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat evidence for opposing roles of 5-HT2 and 5-HT1A receptors. Neuropharmacology. 25:1986;1307-1313.
23. Hales J.R., Khogali M., Fawcett A.A., Mustafa M.K. Circulatory changes associated with heat stroke observations in an experimental animal model. Clin Exp Pharmacol Physiol. 14:1987;761-777.
24. Hales J.R. Hyperthermia and heat illness pathophysiological implications for avoidance and treatment. Ann NY Acad Sci. 813:1997;534-544.
25. Hedner T., Persson B. Effects of a new serotonin antagonist, ketanserin, in experimental and clinical hypertension. Am J Hypertens. 1:1988;317S-323S.
26. Horita A., Dille J. Pyretogenic effect of lysergic acid diethylamide. Science. 120:1954;1100-1101.
27. Iravani M.M., Asari D., Patel J., Wieczorek W.J., Kruk Z.L. Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphe nucleus slices. Synapse. 36:2000;275-285.
28. Jacob J., Lafille C. Charactérisation et detection pharmacologiques des substances hallucinogènes. Arch Int Pharmacodyn. 145:1963;528-545.
29. Krogh A. The anatomy and physiology of capillaries. 2 edn :1922;Yale University Press, New Haven.
30. Liechti M.E., Saur M.R., Gamma A., Hell D., Vollenweider F.X. Psychological and physiological effects of MDMA ("ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans. Neuropsychopharmacology. 23:2000;396-404.
31. Löscher W., Witte U., Fredow G., Ganter M., Bickhardt K. Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs stimulation of 5-HT2 receptors induces malignant hyperthermia. Naunyn Schmiedebergs Arch Pharmacol. 341:1990;483-493.
32. Martinez-Caceres E.M., Rio J., Barrau M., Duran I., Borras C., Tintore M., Montalban X. Amelioration of flulike symptoms at the onset of interferon beta-1b therapy in multiple sclerosis by low-dose oral steroids is related to a decrease in interleukin-6 induction. Ann Neurol. 44:1998;682-685.
33. Mazzola-Pomietto P., Aulakh C.S., Wozniak K.M., Hill J.L., Murphy D.L. Evidence that 1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors. Psychopharmacology (Berl). 117:1995;193-219.
34. McCall R.B., Harris L.T. 5-HT2 receptor agonists increase spontaneous sympathetic nerve discharge. Eur J Pharmacol. 151:1988;113-116.
35. Mechan A.O., Esteban B., O'Shea E., Elliott J.M., Colado M.I., Green A.R. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Br J Pharmacol. 135:2002;170-180.
36. Milroy C.M. Ten years of 'ecstasy'. J Royal Soc Med. 92:1999;68-72.
37. Murakami N., Sakai Y., Ooki S. Behavioral thermoregulation in rats during hyperthermia induced by lysergic acid diethylamide. Neurosci Lett. 20:1980;105-118.
38. Nalivaiko E., Blessing W.W. Raphe region mediates changes in cutaneous vascular tone elicited by stimulation of amygdala and hypothalamus in rabbits. Brain Res. 891:2001;130-137.
39. Nash J.F. Jr, Meltzer H.Y., Gudelsky G.A. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther. 245:1988;873-889.
40. Ohashi K., Saigusa T. Sympathetic nervous responses during cytokine-induced fever in conscious rabbits. Pflügers Arch. 433:1997;691-698.
41. Oka T., Oka K., Hori T. Mechanisms and mediators of psychological stress-induced rise in core temperature. Psychosom Med. 63:2001;476-486.
42. Pedersen N.P., Blessing W.W. Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits. J Neurosci. 21:2001;8648-8654.
43. Rand R.P., Burton A.C., Ing T. The tail of the rat, in temperature regulation and acclimatization. Can J Physiol Pharmacol. 43:1965;257-267.
44. Rattray M. Ecstasy towards an understanding of the biochemical basis of the actions of MDMA. Essays Biochem. 26:1991;77-87.
45. Rittenhouse P.A., Bakkum E.A., Van de Kar L.D. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors. J Pharmacol Exp Ther. 259:1991;58-65.
46. Sadzot B., Baraban J.M., Glennon R.A., Lyon R.A., Leonhardt S., Jan C.R., Titeler M. Hallucinogenic drug interactions at human brain 5-HT2 receptors implications for treating LSD-induced hallucinogenesis. Psychopharmacology (Berl). 98:1989;495-499.
47. Saigusa T., Iriki M. Regional differentiation of sympathetic nerve activity during fever caused by intracerebroventricular injection of PGE2. Pflügers Arch. 411:1988;121-125.
48. Schmidt C.J., Black C.K., Abbate G.M., Taylor V.L. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors. Brain Res. 529:1990;85-90.
49. Shannon M., Battaglia G., Glennon R.A., Titeler M. 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA). Eur J Pharmacol. 102:1984;23-29.
50. Smith J.E., Jansen A.S., Gilbey M.P., Loewy A.D. CNS cell groups projecting to sympathetic outflow of tail artery neural circuits involved in heat loss in the rat. Brain Res. 786:1998;153-164.
51. Tanaka M., Nagashima K., McAllen R.M., Kanosue K. Role of the medullary raphe in thermoregulatory vasomotor control in rats. J Physiol. 540:2002;657-664.
52. Teter C.J., Guthrie S.K. A comprehensive review of MDMA and GHB two common club drugs. Pharmacotherapy. 21:2001;1486-1513.
53. Weinberg J.R., Innes J.A., Thomas K., Tooke J.E., Guz A. Studies on the circulation in normotensive febrile patients. Q J Exp Physiol. 74:1989;301-310.
54. Weiner D.M., Burstein E.S., Nash N., Croston G.E., Currier E.A., Vanover K.E., Harvey S.C., Donohue E., Hansen H.C., Andersson C.M., et al. 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics. J Pharmacol Exp Ther. 299:2001;268-276.
55. Yu Y.H., Blessing W.W. Cutaneous vasoconstriction in conscious rabbits during alerting responses detected by hippocampal theta-rhythm. Am J Physiol. 272:1997;R208-R216.
56. Yu Y.H., Blessing W.W. Amygdala coordinates sudden falls in ear pinna flow in response to unconditioned salient stimuli in conscious rabbits. Neuroscience. 93:1999;135-141.
57. Yu Y.H., Blessing W.W. Neurons in amygdala mediate ear pinna vasoconstriction elicited by unconditioned salient stimuli in conscious rabbits. Auton Neurosci. 87:2001;236-242.
58. Zaretskaia M.V., Zaretsky D.V., Shekhar A., DiMicco J.A. Chemical stimulation of the dorsomedial hypothalamus evokes non-shivering thermogenesis in anesthetized rats. Brain Res. 928:2002;113-125.
59. Zethof T.J., Van der Heyden J.A., Tolboom J.T., Olivier B. Stress-induced hyperthermia as a putative anxiety model. Eur J Pharmacol. 294:1995;125-135.